Ascentage Pharma Group International Financials

Market Capitalization HK$12.36 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-11.22
Forward PE	-12.77
Price to Sales TTM	HK$13.68
Price to Book MRQ	HK$15.83
Enterprise to Revenue	14.11
Enterprise to EBITDA	-48.42

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-06-30
Profit Margin	-39.90%
Operating Margin	22.82%
Return on Assets TTM	-7.14%
Return on Equity TTM	-52.38%

Income Statement

Revenue TTM	HK$959,189,268
Revenue per Share TTM	HK$3.10
Quarterly Revenue Growth	477.30%
Gross Profit TTM	HK$930,034,249
EBITDA	HK$-279,448,652
Net Income to Common TTM	HK$-382,691,475
Diluted EPS TTM	HK$-1.34
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	HK$1,168,743,610
Total Cash per Share MRQ	HK$3.56
Total Debt MRQ	HK$
Total Debt to Equity MRQ	218.96
Current Ratio MRQ	1.84
Book Value per Share MRQ	HK$2.48

Cash Flow

Operating Cash Flow TTM	HK$-756,284,206
Levered Free Cash Flow TTM	HK$-819,115,880

6855 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	315,204,000
Float Shares	205,059,991
Avg 10 Volume	1,521,789
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	28.18%
% Held by Institutions	13.09%

Stock Price Summary

Beta	1.10
Fifty Two Week Low	HK$15.42
Fifty Two Week High	HK$48.85
Fifty Two Week Change	34.92%
Day 50 MA	HK$42.25
Day 200 MA	HK$31.80

Dividends and Splits

Forward Annual Dividend Rate	HK$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	HK$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date